 |
Printer Friendly
Printed from http://www.researchandmarkets.com/reports/552170
Contraception Market Report 2007
|
Description: |
The UK market for contraceptives, as evaluated in this report, comprises four main sectors: hormone-based products; barrier products; intra-uterine device (IUD) products and other methods. Hormone-based products, a publicly funded sector, is the largest sector, having overtaken barrier products, which was the largest sector in 2004. The former continues to perform well, particularly with oral contraceptives, while the latter is currently experiencing difficulties in terms of deflationary pressure on prices, which is affecting value levels.
The total market was worth £164.5m in 2007, which is not a huge sum in comparison with other sectors within the pharmaceutical market. This is a low-revenue industry with a fairly saturated, slow-growing consumer base of mainly women. There is not much incentive for new product development (NPD — although it is happening) and it is telling that the most popular oral contraceptive, Microgynon, was introduced onto the UK market during the 1960s. New products — such as the combined pill Yasmin, from Schering Health and the progestogen-only pill Cerazette, from Organon — have tended to take market share from other products, rather than to stimulate the sector as a whole.
Society is changing and, although levels of sexual activity have not altered much overall, people are becoming sexually active at an earlier age. This impacts on the teenage pregnancy rate, which is still the highest in Europe, and also on the occurrences of sexually transmitted infections (STIs), which are increasing at alarming rates. More education on STIs and more encouragement to use condoms, in particular, is currently a government target. This is boosting volume sales of condoms and encouraging more players to move into the sector, but revenue growth, as a whole, is currently on a downward curve within a heavily discounted market. Manufacturers of condoms have attempted to redress the loss in value through expansion of condom ranges into areas such as lubricants and massagers.
In terms of the protected market, there has been a move towards long-acting reversible contraceptives (LARCs), which the National Institute for Health and Clinical Excellence (NICE) believes will be more effective methods, both in terms of contraception and cost, over the longer term. The Mirena intra-uterine system (IUS) which can last up to 5 years, has been particularly successful and there has been significant growth in the number of prescriptions issued in the UK over the period. Similarly, the contraceptive implant Implanon has become much more popular. With both these methods, women can effectively forget about contraception — certainly in terms of pregnancy — therefore, the risk of unwanted pregnancy is low.
However, for the majority of young women, in particular, the pill — and mainly the combined pill — will continue to be the dominant form of contraception for some years to come. Nonetheless, for both men and women (again, particularly popular with younger adults), the condom is crucial to prevent STIs. Both of these sectors have an assured future — certainly in terms of demographics — and this stable market is firmly underpinned. |
|
Contents: |
Executive Summary
1. Market Definition
REPORT COVERAGE
MARKET SECTORS
Hormone-Based Products Oral Contraceptives Depot Contraceptives Barrier Products Intra-Uterine Products Other Methods
MARKET TRENDS
A Steady Market With Product Development Long-Acting Reversible Contraceptives Become More Popular Condom Sales Are Falling More Contraception Needed Economic Trends Population
Table 1: UK Resident Population Estimates by Sex (000), Mid-Years 2002-2006
Gross Domestic Product
Table 2: UK Gross Domestic Product at Current and Annual Chain-Linked Prices (£m), 2002-2006
Inflation
Table 3: UK Rate of Inflation (%), 2002-2006
Unemployment
Table 4: Actual Number of Unemployed Persons in the UK (million), 2002-2006
2. Market Size
The Total Market
Table 5: The Total UK Contraception Market by Sector by Value (£000), Years Ending May 2003-2007
Figure 1: The Total UK Contraception Market by Sector by Value (£000), Years Ending May 2003-2007
By Market Sector
Hormone-Based Products
Table 6: The Hormone-Based Contraceptive Products Sector by Subsector by Value (£000 and %), Years Ending May 2003-2007
Barrier Methods
Table 7: The Barrier Products Sector by Subsector by Value (£000 and %), Years Ending May 2003-2007
Intra-Uterine Products
Table 8: The Intra-Uterine Products Sector by Subsector by Value (£000 and %), Years Ending May 2003-2007
Other Methods
3. Industry Background
Recent History Number of Companies Employment Distribution
How Robust Is The Market?
Table 9: The Projected UK Female Population by Age, 1971-2021
Table 10: Average Age† of Mothers in England and Wales by Birth Order, 1971-2004
Legislation
Key trade associations and industry bodies
Association of British Pharmaceutical Industry British Pregnancy Advisory Service Brook Advisory Centres Department of Health The NHS Information Centre Family Planning Association Marie Stopes International National Institute for Health and Clinical Excellence National Pharmaceutical Association Royal Pharmaceutical Society of Great Britain
4. Competitor Analysis
THE MARKETPLACE
Market Leaders
Ansell (UK) Ltd
Company Structure Current and Future Development Financial Results
Janssen-Cilag Ltd
Company Structure Current and Future Developments Financial Results
Organon Laboratories Ltd
Company Structure Current and Future Developments Financial Results
Pfizer Ltd
Company Structure Current and Future Developments Financial Results
Schering Health Care Ltd
Company Structure Current and Future Developments Financial Results
SSL International PLC
Company Structure Current and Future Developments Financial Results
Other Companies
Boots and Superdrug Church & Dwight UK Ltd Condomi Health UK Ltd The Female Health Company (UK) PLC FCUK Sexual Health Group PLC Wyeth Europa Ltd
Marketing Activity
Main Media Advertising Expenditure
Table 11: Main Media Advertising Expenditure by Type and Brand, Years Ending March 2006 and 2007
Exhibitions and Trade Shows
5. Strengths, Weaknesses, Opportunities and Threats
6. Buying Behaviour
INTRODUCTION
Contraceptive Use
Table 12: Use of Contraception by Women Aged 16 to 49 in Great Britain by Type (%), 2001/2002-2005/2006
CONTRACEPTIVE USE BY AGE GROUP
Table 13: Use of Contraception by Women in Great Britain by Age (%), 2005/2006
GP Prescriptions
Table 14: Prescription Cost Analysis of Contraceptives by Type (£m), 2002/2003 to 2006/2007
Family Planning
Table 15: Family Planning Services used by Women in Great Britain Aged 16 to 49 (%), 2001/2002-2005/2006
Reasons for Using Condoms
Table 16: Reasons for Using a Condom in Great Britain by Sex (%), 2001/2002 to 2005/2006
Demographics of Condom Purchasing
Table 17: Purchase of Condoms (% of adults), 2006
Frequent Purchasers of Condoms
Table 18: Heavy Purchasers† of Condoms (% of adults), 2006
7. Current Issues
Levels of Sexual Activity
Table 19: Number of Legal Abortions in England and Wales, 1971-2001
Figure 2: Number of Legal Abortions in England and Wales, 1971-2001
Sexually transmitted Infections Government Response LARCs Targeting Young People
8. The Global Market
Introduction Market Size New Products Developing Markets Research and Development
9. Forecasts
Introduction Economic Forecasts Population
Table 20: Forecast UK Resident Population by Sex (000), Mid-Years 2007-2011
Gross Domestic Product
Table 21: Forecast UK Growth in Gross Domestic Product in Real Terms (%), 2007-2011
Inflation
Table 22: Forecast UK Rate of Inflation (%), 2007-2011
Unemployment
Table 23: Forecast Actual Number of Unemployed Persons in the UK (million), 2007-2011
Forecasts 2008 to 2012
Table 24: The Forecast UK Contraception Market by Sector by Value (£m), Years Ending May 2008-2012
Figure 3: The Forecast UK Contraception Market by Sector by Value (£m), Years Ending May 2008-2012
Market Growth
Figure 4: The Total UK Contraception Market by Value (£m), Years Ending May 2003-2012
Future Trends
New Product Development Increasing Awareness Social Trends Over the Counter
10. Company Profiles
Ansell (uk) Ltd Janssen-cilag Ltd Organon Laboratories Ltd Pfizer Ltd Schering Health Care Ltd SSL International Plc
11. Consumer Confidence
METHODOLOGY KEY FINDINGS THIS QUARTER THE WILLINGNESS TO BORROW
Confidence Improves
Table A: The Average Amount Consumers Are Willing to Borrow in Order to Purchase Expensive Items at Current and Constant November 2004 Prices (£ and £bn), February 2006-2007
Willingness to Borrow Slips Slightly
Table B: The Number of Adults Willing to Borrow in Order to Purchase Expensive Items (000 and %), February 2006-2007
SPENDING FROM SAVINGS
Slight Increase in Spending from Savings
Table C: The Average Amount Consumers Are Willing to Spend from Savings in Order to Purchase Expensive Items at Current and Constant November 2004 Prices (£ and £bn), February 2006-2007
Saving Grows in Relative Importance
Table D: The Average Amounts Adults Are Confident Spending to Purchase Expensive Items (£ and %), February 2006-2007
12. Further Sources
Associations General Sources Government Publications Other Sources Bisnode Sources |
|
Companies Mentioned |
- Ansell (uk) Ltd
- Janssen-cilag Ltd
- Organon Laboratories Ltd
- Pfizer Ltd
- Schering Health Care Ltd
- SSL International Plc
- Association of British Pharmaceutical Industry
- British Pregnancy Advisory Service
- Brook Advisory Centres
- Department of Health
- The NHS Information Centre
- Family Planning Association
- Marie Stopes International
- National Institute for Health and Clinical Excellence
- National Pharmaceutical Association
- Royal Pharmaceutical Society of Great Britain
- Boots and Superdrug
- Church & Dwight UK Ltd
- Condomi Health UK Ltd
- The Female Health Company (UK) PLC
- FCUK
- Sexual Health Group PLC
- Wyeth Europa Ltd |
|
Ordering: |
Order Online - visit http://www.researchandmarkets.com/reports/552170
Order by Fax - using the order form below
Order By Post - print the order form below and send to
 |
Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.
|
|
|
 |
Page 1 of 2 Printed 27/11/2009 16:39:45 |
|
Fax Order Form
To place an order via fax simply print this form, fill in the information below and
fax the completed form to
646-607-1907 (from USA) or +353 1 6849977 (from Rest of World). If you have any questions please email help@researchandmarkets.net
Order information
Please verify that the product information is correct and select the format you require.
|
|
|
Product Name: |
Contraception Market Report 2007
|
|
Web Address: |
http://www.researchandmarkets.com/reports/552170
|
|
Office Code: |
|
OC8HJNPOUMUXU
|
Report formats
Please enter the quantity of the report format you require.
|
|
Format
|
Quantity
|
Price
|
|
Electronic (PDF)
- Single User
|
|
€774.00
|
|
Hard Copy
|
|
€950.00 + EUR€ 50.00 Shipping/Handling *
|
* Shipping/Handling is only charged once per order.
Contact information
Please enter all the information below in BLOCK CAPITALS.
 |
|
First Name: |
Last Name: |
|
Email Address: |
 |
|
Job Title: |
 |
|
Organisation: |
 |
|
Address: |
 |
|
City: |
 |
|
Postal/Zip Code: |
 |
|
Country: |
 |
|
Phone Number: |
 |
|
Fax Number: |
 |
|
Please fax this form to: (646) 607-1907 or (646) 964-6609 (from USA) +353-1-481-1716 or +353-1-653-1571 (from Rest of World)
 |
Page 2 of 2 Printed 27/11/2009 16:39:45
|
|
Payment information
Please indicate the payment method you would like to use by selecting the appropriate
box.
|
|
|
|
American Express
|
|
Diners Club
|
|
Master Card
|
|
Visa
|
|
|
|
 |
|
Cardholder's Name: |
 |
|
|
|
Cardholder's Signature: |
 |
|
|
|
Expiry Date: |
/  |
|
|
|
Card Number: |
 |
|
|
|
CVV Security Code: |
 |
|
|
|
Issue Date: |
/ (Diners
Club only)
|
|
|
|
 |
Please post the check, accompanied by this form, to:
Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.
|
|
 |
|
 |
Please transfer funds to:
 |
|
Account number: |
83313083 |
|
Sort code: |
98-53-30 |
|
Swift code: |
ULSBIE2D |
|
IBAN number: |
IE78ULSB98533083313083 |
|
Bank Address: |
Ulster Bank,
27-35 Main St,
Blackrock,
Co. Dublin,
Ireland. |
|
|
|
If you have a Marketing Code please enter it below:
|
|
|
Marketing Code: |
 |
|
Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp
|
|
Please fax this form to: (646) 607-1907 or (646) 964-6609 (from USA) +353-1-481-1716 or +353-1-653-1571 (from Rest of World)
|
 |
 |
|
|